Elite Medical Global Limited is a modern, high-technology medical diagnostics and precision medicine service platform headquartered in Hong Kong.

Rooted in Hong Kong and serving the Asian region, Elite Medical collaborates with regional public and private health providers, public health organizations, and scientific research institutions. We deliver precision diagnostic services focused on oncology, genetic/rare diseases, infectious diseases of unknown etiology, and pharmacogenomics.

Our precision medicine approach offers patients diverse advanced testing technologies. Through sophisticated multi-omics analyses, including genomics, proteomics, and metabolomics, we elucidate individual genetic profiles and disease susceptibility. Leveraging Next Generation Sequencing (NGS) technologies and high-precision molecular detection methodologies, we accurately identify disease-associated genetic variants. This enables the formulation of tailored, personalized diagnostic and therapeutic strategies for each patient.

These advanced diagnostic capabilities enhance the accuracy of early disease screening, facilitating timely intervention and enabling ultra-early treatment. Furthermore, they empower physicians to develop highly precise treatment regimens, implementing the goal of targeted therapy – administering the right treatment for the specific condition. This commitment drives the evolution of healthcare towards greater precision and personalization.

Elite Medical is dedicated to pioneering the new era of global precision medicine and advancing the frontier of personalized healthcare.